Home/Filings/4/0001213900-24-008454
4//SEC Filing

Dubin Michael F 4

Accession 0001213900-24-008454

CIK 0001708331other

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 4:23 PM ET

Size

11.7 KB

Accession

0001213900-24-008454

Insider Transaction Report

Form 4
Period: 2024-01-29
Transactions
  • Award

    Stock Option (right to buy)

    2024-01-29+25,00025,000 total
    Exercise: $0.32Exp: 2034-01-28Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]These options vest pro rata on a monthly basis for 12 months commencing one year after the date of grant.

Issuer

Virpax Pharmaceuticals, Inc.

CIK 0001708331

Entity typeother

Related Parties

1
  • filerCIK 0001876497

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:23 PM ET
Size
11.7 KB